Iron and microbial infection

Nature Reviews Microbiology

Volumn 2, Issue 12, 2004, Pages 946-953

  Schaible, Ulrich E ^a   Kaufmann, Stefan H E ^a  

^a MAX PLANCK INSTITUTE FOR INFECTION BIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

IRON; NITROGEN; OXYGEN;

EVOLUTION; HOST; HOST PATHOGEN INTERACTION; IMMUNE RESPONSE; INFECTION; METABOLISM; MICROORGANISM; NONHUMAN; NUTRIENT; PRIORITY JOURNAL; REVIEW;

ANIMALS; BACTERIA; BACTERIAL INFECTIONS; HUMANS; IMMUNITY, ACTIVE; IMMUNITY, CELLULAR; IMMUNITY, NATURAL; IRON; NITRIC OXIDE; SUPEROXIDES;

EID: 9444246510     PISSN: 17401526     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrmicro1046     Document Type: Review

References (73)

1. Hentze, M. W., Muckenthaler, M. U. & Andrews, N. C. Balancing acts: molecular control of mammalian iron metabolism. Cell 117 285-297 (2004).
2. Kaplan, J. Mechanisms of cellular iron acquisition: another iron in the fire. Cell 111, 603-606 (2002).
3. Andrews, S. C., Robinson, A. K. & Rodriguez-Quinones, F. Bacterial iron homeostasis. FEMS Microbiol. Rev. 27, 215-237 (2003).
4. Picard, V., Govoni, G., Jabado, N. & Gros, P. Nramp 2 (DCT1 /DMT1) expressed at the plasma membrane transports iron and other divalent cations into a calcein-accessible cytoplasmic pool. J. Biol. Chem. 275, 35738-35745 (2000).
5. Donovan, A. et al. Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter. Nature 403, 776-781 (2000).
6. Ganz, T. Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood 102, 783-788 (2003).
7. Gruenheid, S. et al. The iron transport protein NRAMP2 is an integral membrane glycoprotein that colocalizes with transferrin in recycling endosomes. J. Exp. Med. 189, 831-841 (1999).
8. Robson, K. J. et al. Recent advances in understanding haemochromatosis: a transition state. J. Med. Genet. 41, 721-730 (2004).
9. Pietrangelo, A. Hereditary hemochromatosis - a new look at an old disease. N. Engl. J. Med. 350, 2383-2397 (2004).
10. Eisenbach, C., Gehrke, S. G. & Stremmel, W. Iron, the HFE gene, and hepatitis C. Clin. Liver Dis. 8, 775-785 (2004).
11. Bennett, M. J., Lebron, J. A. & Bjorkman, P. J. Crystal structure of the hereditary haemochromatosis protein HFE complexed with transferrin receptor. Nature 403, 46-53 (2000).
12. Enns, C. A. Pumping iron: the strange partnership of the hemochromatosis protein, a class I MHC homolog, with the transferrin receptor. Traffic 2, 167-174 (2001).
13. Nicolas, G. et al. Constitutive hepcidin expression prevents iron overload in a mouse model of hemochromatosis. Nature Genet. 34, 97-101 (2003).
14. Canonne-Hergaux, F., Gruenheid, S., Govoni, G. & Gros, P. The Nramp1 protein and its role in resistance to infection and macrophage function. Proc. Assoc. Am. Physicians 111, 283-289 (1999).
15. Hackam, D J. et al. Host resistance to intracellular infection: mutation of natural resistance-associated macrophage protein 1 (Nramp1) impairs phagosomal acidification. J. Exp. Med. 188, 351-364 (1998).
16. Jabado, N., Cuellar-Mata, P., Grinstein, S. & Gros, P. Iron chelators modulate the fusogenic properties of Salmonella containing phagosomes. Proc. Natl Acad. Sci. USA 100, 6127-6132 (2003).
17. Collins, H. L., Kaufmann, S. H. E. & Schaible, U. E. Iron chelation via deferoxamine exacerbates experimental salmonellosis via inhibition of the nicotinamide adenine dinucleotide phosphate oxidase-dependent respiratory burst. J. Immunol. 168, 3458-3463 (2002).
18. Mogues, T., Goodrich, M. E., Ryan, L., LaCourse, R. & North, R. J. The relative importance of T cell subsets in immunity and immunopathology of airborne Mycobacterium tuberculosis infection in mice. J. Exp. Med. 193, 271-80 (2001)
19. Posey, J. E. & Gherardini, F. C. Lack of a role for iron in the Lyme disease pathogen. Science 288, 1651-1653 (2000).
20. Weinberg, E. D. Iron and infection. Microbiol. Rev. 42, 45-66 (1978)
21. Ratledge, C. & Dover, L. G. Iron metabolism in pathogenic bacteria. Annu. Rev. Microbiol. 54, 881-941 (2000).
22. Ratledge, C. Iron, mycobacteria and tuberculosis. Tuberculosis (Edinb.) 84, 110-130 (2004).
23. Brown, J. S. & Holden, D. W. Iron acquisition by Gram-positive bacterial pathogens. Microbes Infect. 4, 1149-1156 (2002).
24. Agranoff, D. D. & Krishna, S. Metal ion homeostasis and intracellular parasitism. Mol. Microbiol. 28, 403-412 (1998).
25. Rodriguez, G. M. & Smith, I. Mechanisms of iron regulation in mycobacteria: role in physiology and virulence. Mol. Microbiol. 47, 1485-1494 (2003).
26. Manabe, Y. C., Saviola, B. J., Sun, L., Murphy, J. R. & Bishai, W. R. Attenuation of virulence in Mycobacterium tuberculosis expressing a constitutively active iron repressor. Proc. Natl Acad. Sci. USA 96, 12844-12848 (1999).
27. Gold, B., Rodriguez, G. M., Marras, S. A., Pentecost, M. & Smith, I. The Mycobacterium tuberculosis IdeR is a dual functional regulator that controls transcription of genes involved in iron acquisition, iron storage and survival in macrophages. Mol. Microbiol. 42, 851-865 (2001).
28. Skaar, E. P., Humayun, M., Bae, T., DeBord, K. L. & Schneewind, O. Iron-source preference of Staphylococcus aureus infections. Science 305, 1626-1628 (2004).
29. Al Younes, H. M., Rudel, T., Brinkmann, V., Szczepek A. J. & Meyer, T. F. Low iron availability modulates the course of Chlamydia pneumoniae infection. Cell. Microbiol. 3, 427-437 (2001).
30. Byrd, T. F. & Horwitz, M. A. Lactoferrin inhibits or promotes Legionella pneumophila intracellular multiplication in nonactivated and interferon ã-activated human monocytes depending upon its degree of iron saturation. Iron-lactoferrin and nonphysiologic iron chelates reverse monocyte activation against Legionella pneumophila. J. Clin. Invest. 88, 1103-1112 (1991).
31. Olakanmi, O., Britigan, B. E. & Schlesinger, L. S. Gallium disrupts iron metabolism of mycobacteria residing within human macrophages. Infect. Immun. 68, 5619-5627 (2000).
32. Schaible, U. E., Collins, H. L., Priem, F. & Kaufmann, S. H. E. Correction of the iron overload defect in β-2-microglobulin knockout mice by lactoferrin abolishes their increased susceptibility to tuberculosis. J. Exp. Med. 196, 1507-1513 (2002).
33. Lounis, N., Truffot-Pernot, C., Grosset, J., Gordeuk, V. R. & Boelaert, J. R. Iron and Mycobacterium tuberculosis infection. J. Clin. Virol. 20, 123-126 (2001).
34. Schaible, U., Collins, H. & Kaufmann, S. H. E. Confrontation between intracellular bacteria and the immune system. Adv. Immunol. 71, 267-377 (1999).
35. Olakanmi, O., Schlesinger, L. S., Ahmed, A. & Britigan, B. E. Intraphagosomal Mycobacterium tuberculosis acquires iron from both extracellular transferrin and intracellular iron pools. Impact of interferon-ã and hemochromatosis. J. Biol. Chem. 277, 49727-49734 (2002).
36. Bockmann, R., Dickneite, C., Middendorf, B., Goebel, W. & Sokolovic, Z. Specific binding of the Listeria monocytogenes transcriptional regulator PrfA to target sequences requires additional factor(s) and is influenced by iron. Mol. Microbiol. 22, 643-653 (1996).
37. Deneer, H. G, Healey, V. & Boychuk, I. Reduction of exogenous ferric iron by a surface-associated ferric reductase of Listeria spp. Microbiology 141, 1985-1992 (1995).
38. Larson, J. A., Howie, H. L. & So, M. Neisseria meningitidis accelerates ferritin degradation in host epithelial cells to yield an essential iron source. Mol. Microbiol. 53, 807-820 (2004).
39. Schaible, U. E., Sturgill-Koszycki, S., Schlesinger, P. H. & Russell, D. G. Cytokine activation leads to acidification and increases maturation of Mycobacterium avium-containing phagosomes in murine macrophages. J. Immunol. 160, 1290-1296 (1998).
40. Byrd, T. F. & Horwitz, M. A. Regulation of transferrin receptor expression and ferritin content in human mononuclear phagocytes. Coordinate upregulation by iron transferrin and downregulation by interferon γ. J. Clin. Invest. 91, 969-976 (1993).
41. Timm, J. et al. Differential expression of iron-, carbon-, and oxygen-responsive mycobacterial genes in the lungs of chronically infected mice and tuberculosis patients. Proc. Natl Acad. Sci. USA 100, 14321-14326 (2003).
42. Moalem, S., Weinberg, E. D. & Percy, M. E. Hemochromatosis and the enigma of misplaced iron: implications for infectious disease and survival. Biometals 17, 135-139 (2004).
43. Murray, M. J., Murray, A. B., Murray, M. B. & Murray, C. J. The adverse effect of iron repletion on the course of certain infections. Br. Med. J. 2, 1113-1115 (1978).
44. Weinberg, E. D. Iron loading and disease surveillance. Emerg. Infect. Dis. 5, 346-352 (1999).
45. Trousseau, A. True and false chlorosis. Lectures on Clinical Medicine 5, 95-117 (1872).
46. Gordeuk, V. R. African iron overload. Semin. Hematol. 39, 263-269 (2002).
47. Gangaidzo, I. T. et al. Association of pulmonary tuberculosis with increased dietary iron. J. Infect. Dis. 184 936-939 (2001).
48. Gordeuk, V. R., McLaren, C. E., MacPhail, A. P., Deichsel, G. & Bothwell, T. H. Associations of iron overload in Africa with hepatocellular carcinoma and tuberculosis: Strachan's 1929 thesis revisited. Blood 87, 3470-3476 (1996).
49. Gordeuk, V. et al. Iron overload in Africa. Interaction between a gene and dietary iron content. N. Engl. J. Med. 326 95-100 (1992).
50. Santos, M., Clevers, H., De Sousa, M. & Marx, J. J. Adaptive response of iron absorption to anemia, increased erythropoiesis, iron deficiency, and iron loading in β2-microglobulin knockout mice. Blood 91, 3059-3065 (1998).
51. Rolph, M. S. et al. MHC class Ia-restricted T cells partially account for β2-microglobulin-dependent resistance to Mycobacterium tuberculosis. Eur. J. Immunol. 31, 1944-1949 (2001).
52. Behar, S. M., Dascher, C. C., Grusby, M. J., Wang, C. R. & Brenner, M. B. Susceptibility of mice deficient in CD1D or TAP1 to infection with Mycobacterium tuberculosis. J. Exp. Med. 189, 1973-1980 (1999).
53. Bartfay, W. J. & Bartfay, E. Systemic oxygen-free radical production in iron-loaded mice. West J. Nurs. Res. 22, 927-935 (2000).
54. Alford, C. E., King, T. E. Jr & Campbell, P. A. Role of transferrin, transferrin receptors, and iron in macrophage listericidal activity. J. Exp. Med. 174, 459-466 (1991).
55. Ward, P. P., Uribe-Luna, S. & Conneely, O. M. Lactoferrin and host defense. Biochem. Cell Biol. 80, 95-102 (2002).
56. Vorland, L. H. Lactoferrin: a multifunctional glycoprotein. APMIS 107, 971-981 (1999).
57. Singh, P. K., Parsek, M. R., Greenberg, E. P. & Welsh, M. J. A component of innate immunity prevents bacterial biofilm development. Nature 417, 552-555 (2002).
58. Griffiths, E. A. et al. In vivo effects of bifidobacteria and lactoferrin on gut endotoxin concentration and mucosal immunity in Balb/c mice. Dig. Dis. Sci. 49, 579-589 (2004).
59. Tanida, T., Rao, F., Hamada, T., Ueta, E. & Osaki, T. Lactoferrin peptide increases the survival of Candida albicans inoculated mice by upregulating neutrophil and macrophage functions, especially in combination with amphotericin B and granulocyte-macrophage colony-stimulating factor. Infect. Immun. 69, 3883-3890 (2001).
60. Ueta, E., Tanida, T., & Osaki, T. A novel bovine lactoferrin peptide, FKCRRWQWRM, suppresses Candida cell growth and activates neutrophils. J. Pept. Res. 57, 240-249 (2001).
61. Tanida, T., Rao, F., Hamada, T., Ueta, E. & Osaki, T. Lactoferrin peptide increases the survival of Candida albicans inoculated mice by upregulating neutrophil and macrophage functions, especially in combination with amphotericin B and granulocyte-macrophage colony-stimulating factor. Infect. Immun. 69, 3883-3890 (2001).
62. Yamauchi, K., Tomita, M., Giehl, T. J. & Ellison, R. T. Antibacterial acivity of lactoferrin and a pepsin-derived lactoferrin peptide fragment. Infect. Immun. 61, 719-728 (1993).
63. Walker, E. M. Jr & Walker, S. M. Effects of iron overload on the immune system. Ann. Clin. Lab. Sci. 30, 354-365 (2000).
64. Kuvibidila, S. R. & Porretta, C. Iron deficiency and in vitro iron chelation reduce the expression of cluster of differentiation molecule (CD)28 but not CD3 receptors on murine thymocytes and spleen cells. Br. J. Nutr. 90, 179-189 (2003).
65. Grant, S. M., Wiesinger, J. A., Beard, J. L. & Cantorna, M. T. Iron-deficient mice fail to develop autoimmune encephalomyelitis. J. Nutr. 133, 2635-2638 (2003).
66. Omara, F. O. & Blakley, B. R. The IgM and IgG antibody responses in iron-deficient and iron-loaded mice. Biol. Trace Elem. Res. 46, 155-161 (1994).
67. Omara, F. O. & Blakley, B. R. The effects of iron deficiency and iron overload on cell-mediated immunity in the mouse. Br. J. Nutr. 72, 899-909 (1994).
68. Cunningham-Rundles, S. et al. Effect of transfusional iron overload on immune response. J. Infect. Dis. 182, S115-S121 (2000).
69. Wanachiwanawin, W. Infections in E,-β-thalassemia. J. Pediatr. Hematol. Oncol. 22, 581-587 (2000).
70. de Sousa, M. & Porto, G. The immunological system in hemochromatosis. J. Hepatol. 28, (Suppl. 1) 1-7 (1998).
71. Bisti, S. et al. The outcome of Leishmania major experimental infection in BALB/c mice can be modulated by exogenously delivered iron. Eur. J. Immunol. 30, 3732-3740 (2000).
72. Weiss, G. et al. Associations between cellular immune effector function, iron metabolism, and disease activity in patients with chronic hepatitis C virus infection. J. Infect. Dis. 180, 1452-1458 (1999).
73. Nemeth, E. et al. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J. Clin. Invest. 113, 1271-1276 (2004).